openPR Logo
Press release

Anti Malarial Drugs Market to Reach US$ 1333.16 Mn by 2030 with 4.3% CAGR

01-10-2025 11:43 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

Anti-Malarial Drugs Market

Anti-Malarial Drugs Market

The global anti-malarial drugs market is projected to experience significant growth due to advancements in research and rising awareness about malaria prevention. The market was valued at US $ 992.87 Mn. in 2023 and is expected to grow at a CAGR of 4.3% from 2024 to 2030, reaching nearly US $ 1333.16 Mn. by 2030.

๐†๐ž๐ญ ๐š ๐œ๐ฅ๐จ๐ฌ๐ž๐ซ ๐ฅ๐จ๐จ๐ค ๐š๐ญ ๐ญ๐ก๐ž ๐ ๐š๐ฆ๐ž-๐œ๐ก๐š๐ง๐ ๐ข๐ง๐  ๐ฉ๐ซ๐จ๐๐ฎ๐œ๐ญ๐ฌ ๐๐ซ๐ข๐ฏ๐ข๐ง๐  ๐ฌ๐ฎ๐œ๐œ๐ž๐ฌ๐ฌ :https://www.maximizemarketresearch.com/request-sample/24938/

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐•๐ข๐ž๐ญ๐ง๐š๐ฆ

Vietnam's anti-malarial drugs market has shown steady growth due to government initiatives targeting malaria elimination. Collaborative efforts with global organizations such as the ๐–๐จ๐ซ๐ฅ๐ ๐‡๐ž๐š๐ฅ๐ญ๐ก ๐Ž๐ซ๐ ๐š๐ง๐ข๐ณ๐š๐ญ๐ข๐จ๐ง (๐–๐‡๐Ž) have led to a reduction in malaria cases. Additionally, partnerships between ๐ฅ๐จ๐œ๐š๐ฅ ๐ก๐ž๐š๐ฅ๐ญ๐ก๐œ๐š๐ซ๐ž ๐ฉ๐ซ๐จ๐ฏ๐ข๐๐ž๐ซ๐ฌ and pharmaceutical companies are driving market growth.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ฒ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐“๐ก๐š๐ข๐ฅ๐š๐ง๐

Thailand is focusing on innovative treatment options to combat drug-resistant malaria strains. Recent mergers, such as the collaboration between ๐๐จ๐ฏ๐š๐ซ๐ญ๐ข๐ฌ and ๐ฅ๐จ๐œ๐š๐ฅ ๐๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐จ๐ซ๐ฌ, are expected to streamline drug availability. Thailand's National Malaria Elimination Strategy 2024-2030 is a key driver for market expansion.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐‰๐š๐ฉ๐š๐ง

Japan's pharmaceutical sector has been investing in advanced research to develop next-generation anti-malarial drugs. Recent investments by ๐“๐š๐ค๐ž๐๐š ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ into malaria drug trials underline the country's commitment to tackling global health challenges. Strategic collaborations with regional healthcare providers also contribute to market consolidation.

๐”๐ง๐ฅ๐จ๐œ๐ค ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ž๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž ๐ฏ๐ข๐š ๐ญ๐ก๐ž ๐ฅ๐ข๐ง๐ค @https://www.maximizemarketresearch.com/request-sample/24938/

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐‚๐ก๐ข๐ง๐š

China has made remarkable progress in eliminating malaria, as highlighted by its certification from WHO in 2021. The market is witnessing a pivot toward manufacturing and exporting anti-malarial drugs. Companies like ๐’๐ก๐š๐ง๐ ๐ก๐š๐ข ๐๐ก๐š๐ซ๐ฆ๐š๐œ๐ž๐ฎ๐ญ๐ข๐œ๐š๐ฅ๐ฌ have increased their R&D investments, aiming for innovative treatments that can cater to global markets.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐“๐ซ๐ž๐ง๐๐ฌ ๐ข๐ง ๐’๐จ๐ฎ๐ญ๐ก ๐Š๐จ๐ซ๐ž๐š

South Korea's market is characterized by technological advancements in drug formulation. Companies like ๐‚๐ž๐ฅ๐ฅ๐ญ๐ซ๐ข๐จ๐ง and ๐’๐š๐ฆ๐ฌ๐ฎ๐ง๐  ๐๐ข๐จ๐ฅ๐จ๐ ๐ข๐œ๐ฌ are focusing on biosimilar development for anti-malarial treatments. Collaborations with African healthcare initiatives have also opened new opportunities for South Korean manufacturers.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐†๐ซ๐จ๐ฐ๐ญ๐ก ๐Ž๐ฉ๐ฉ๐จ๐ซ๐ญ๐ฎ๐ง๐ข๐ญ๐ข๐ž๐ฌ ๐ข๐ง ๐’๐ข๐ง๐ ๐š๐ฉ๐จ๐ซ๐ž

Singapore is emerging as a hub for clinical trials and pharmaceutical innovation. Recent partnerships between ๐†๐ฅ๐š๐ฑ๐จ๐’๐ฆ๐ข๐ญ๐ก๐Š๐ฅ๐ข๐ง๐ž (๐†๐’๐Š) and local research centers have enhanced drug development processes. The government's strong focus on healthcare innovation further bolsters the market outlook.

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐”๐ฉ๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ž ๐”๐ง๐ข๐ญ๐ž๐ ๐’๐ญ๐š๐ญ๐ž๐ฌ

The US remains one of the leading markets for anti-malarial drugs due to significant investments in R&D and robust healthcare infrastructure. Companies such as ๐๐Ÿ๐ข๐ณ๐ž๐ซ and ๐Œ๐ž๐ซ๐œ๐ค have made strides in malaria vaccine research, complementing the drug market. Strategic acquisitions, such as GSK's recent partnership with US-based biotech firms, underscore consolidation trends.

๐„๐ฑ๐ฉ๐ฅ๐จ๐ซ๐ž ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐๐š๐ญ๐š ๐š๐ง๐ ๐ข๐ง๐ฌ๐ข๐ ๐ก๐ญ๐ฌ ๐›๐ฒ ๐ฏ๐ข๐ž๐ฐ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฌ๐š๐ฆ๐ฉ๐ฅ๐ž @https://www.maximizemarketresearch.com/request-sample/24938/

๐€๐ง๐ญ๐ข-๐Œ๐š๐ฅ๐š๐ซ๐ข๐š๐ฅ ๐ƒ๐ซ๐ฎ๐ ๐ฌ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‚๐จ๐ง๐ฌ๐จ๐ฅ๐ข๐๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐„๐ฎ๐ซ๐จ๐ฉ๐ž

Europe is focusing on sustainable manufacturing practices in the anti-malarial drugs market. Companies like ๐’๐š๐ง๐จ๐Ÿ๐ข and ๐๐š๐ฒ๐ž๐ซ have intensified their efforts in producing affordable treatments. The region also benefits from initiatives like the European & Developing Countries Clinical Trials Partnership (EDCTP), fostering cross-border research collaborations.

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง:

๐›๐ฒ ๐ƒ๐ซ๐ฎ๐  ๐“๐ฒ๐ฉ๐ž

Quinine
Chloroquine
Amodiaquine
Pyrimethamine
Others

A medication called quinine is used to treat babesiosis and malaria. When artesunate is unavailable, quinine is used to treat malaria because Plasmodium falciparum is resistant to chloroquine. Patients with malaria can have fewer Plasmodium parasites in their blood by taking artemisinin. Artemisinin side effects include liver problems, tremors, nausea, vomiting, and skin rashes.

๐›๐ฒ ๐Œ๐š๐ฅ๐š๐ซ๐ข๐š ๐“๐ฒ๐ฉ๐ž

Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale

The two most dangerous species of malaria are Plasmodium falciparum and Plasmodium vivax. The most prevalent malaria parasite in South Africa, Plasmodium falciparum, is also the one that kills the most people worldwide. Plasmodium falciparum grows rapidly, resulting in blocked blood arteries and significant blood loss. Asia Pacific is where Plasmodium vivax is primarily found. Each year, Plasmodium vivax causes malaria in 19-50 million people.

๐›๐ฒ ๐Œ๐ž๐œ๐ก๐š๐ง๐ข๐ฌ๐ฆ ๐จ๐Ÿ ๐€๐œ๐ญ๐ข๐จ๐ง

Resistance
Prevention

๐›๐ฒ ๐ƒ๐ข๐ฌ๐ญ๐ซ๐ข๐›๐ฎ๐ญ๐ข๐จ๐ง ๐‚๐ก๐š๐ง๐ง๐ž๐ฅ

Hospitals & Retail Pharmacy
E-Commerce
Others

๐†๐ž๐ญ ๐š ๐๐ž๐ญ๐š๐ข๐ฅ๐ž๐ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ:https://www.maximizemarketresearch.com/market-report/global-anti-malarial-drugs-market/24938/

๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ:

1. Mylan Labs
2. Cipla
3. GlaxoSmithKline
4. Novartis
5. Roche
6. Bayer AG
7. Lincoln Pharmaceuticals
8. Strides Pharma Science
9. Glenmark Pharmaceuticals
10.Alliance Pharmaceuticals
11.F. Hoffmann-La Roche AG
12.Alvizia Healthcare Pvt. Ltd.
13.Ipca Laboratories Ltd.
14.Merck & Co., Inc
15.Sun Pharmaceutical Industries Ltd.
16.Zydus Cadila.
17.Ranbaxy Laboratories

๐‚๐ก๐ž๐œ๐ค ๐จ๐ฎ๐ญ ๐จ๐ฎ๐ซ ๐ญ๐ซ๐ž๐ง๐๐ข๐ง๐  ๐ฌ๐ญ๐ฎ๐๐ข๐ž๐ฌ ๐ญ๐จ ๐ฎ๐ง๐๐ž๐ซ๐ฌ๐ญ๐š๐ง๐ ๐ข๐ง๐๐ฎ๐ฌ๐ญ๐ซ๐ฒ ๐ฌ๐ก๐ข๐Ÿ๐ญ๐ฌ :

โ™ฆ Thin Boiling Starch Market https://www.maximizemarketresearch.com/market-report/thin-boiling-starch-market/147120/

โ™ฆ Wireless Keyboard Market https://www.maximizemarketresearch.com/market-report/global-wireless-keyboard-market/3701/

โ™ฆ Global Cesium Market https://www.maximizemarketresearch.com/market-report/global-cesium-market/89395/

โ™ฆ Industrial Palletizing Robots Market https://www.maximizemarketresearch.com/market-report/industrial-palletizing-robots-market/77409/

โ™ฆ Operational Technology Market https://www.maximizemarketresearch.com/market-report/operational-technology-market/171620/

โ™ฆ Global Fall Detection System Market https://www.maximizemarketresearch.com/market-report/global-fall-detection-system-market/25573/

โ™ฆ Global Conductive Inks Market https://www.maximizemarketresearch.com/market-report/global-conductive-inks-market/33202/

โ™ฆ Enterprise Risk Management Market https://www.maximizemarketresearch.com/market-report/global-enterprise-risk-management-market/39991/

โ™ฆ Global Soy Milk Market https://www.maximizemarketresearch.com/market-report/global-soy-milk-market/77593/

โ™ฆ Ductless HVAC System Market https://www.maximizemarketresearch.com/market-report/global-ductless-hvac-system-market/28305/

๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ:

MAXIMIZE MARKET RESEARCH PVT. LTD.
3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
+91 9607365656
sales@maximizemarketresearch.com

๐€๐›๐จ๐ฎ๐ญ ๐”๐ฌ:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anti Malarial Drugs Market to Reach US$ 1333.16 Mn by 2030 with 4.3% CAGR here

News-ID: 3810518 • Views: โ€ฆ

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Smart Indoor Garden Market to Grow at 9.4% CAGR, Reaching USD 250.12 Million by 2032
01-13-2026 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Smart Indoor Garden Market to Grow at 9.4% CAGR, Reaching USD 250.12 Million by โ€ฆ
Smart Indoor Garden Market: Growth, Dynamics, and Future Outlook The Smart Indoor Garden Market size was valued at USD 2.18 Billion in 2024, and the total Smart Indoor Garden Market revenue is expected to grow at a CAGR of 9.4% from 2025 to 2032, reaching nearly USD 4.45 Billion. Market Overview The Smart Indoor Garden Market represents a fast-growing segment within the smart home and urban farming ecosystem. These systems enable consumers toโ€ฆ
Sports Apparel Market Poised to Reach USD 383.89 Billion by 2032 at 6.7% CAGR
01-13-2026 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Sports Apparel Market Poised to Reach USD 383.89 Billion by 2032 at 6.7% CAGR
Sports Apparel Market: Growth, Dynamics, and Future Outlook The Sports Apparel Market size was valued at USD 228.50 Billion in 2024, and the total Sports Apparel Market revenue is expected to grow at a CAGR of 6.7% from 2025 to 2032, reaching nearly USD 383.89 Billion. Market Overview The Sports Apparel Market represents a fast-growing segment of the global apparel industry, encompassing clothing designed for sports, fitness, athleisure, and outdoor activities. The marketโ€ฆ
Titanium Market Growth at 6.2% CAGR to Reach USD 47.96 Bn by 2032
01-13-2026 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Titanium Market Growth at 6.2% CAGR to Reach USD 47.96 Bn by 2032
Titanium Market: Growth, Dynamics, and Future Outlook The Titanium Market size was valued at USD 26.45 Billion in 2024, and the total Titanium Market revenue is expected to grow at a CAGR of 5.2% from 2025 to 2032, reaching nearly USD 39.72 Billion. Market Overview The Titanium Market plays a crucial role across multiple industries, including aerospace, automotive, medical devices, chemical processing, and construction. Titanium is widely preferred due to its exceptional strength-to-weightโ€ฆ
Vodka Market Growth Outlook: 8.94% CAGR Driving USD 115.10 Billion Valuation by 2032
01-13-2026 | Advertising, Media Consulting, โ€ฆ
MAXIMIZE MARKET RESEARCH PVT. LTD.
Vodka Market Growth Outlook: 8.94% CAGR Driving USD 115.10 Billion Valuation by โ€ฆ
Vodka Market: Growth, Dynamics, and Future Outlook The Vodka Market size was valued at USD 48.26 Billion in 2024, and the total Vodka Market revenue is expected to grow at a CAGR of 5.2% from 2025 to 2032, reaching nearly USD 72.15 Billion. Market Overview The Vodka Market represents a major segment of the global alcoholic beverages industry, driven by rising consumption across both developed and emerging economies. Vodka remains one of theโ€ฆ

All 5 Releases


More Releases for Plasmodium

12-11-2025 | Health & Medicine
Exactitude Consultancy
Plasmodium vivax Malaria Market is projected to reach USD 2.14 billion by 2034
The global Plasmodium vivax (P. vivax) Malaria Market was valued at USD 1.21 billion in 2024 and is projected to reach USD 2.14 billion by 2034, growing at a CAGR of 6.0% during 2025-2034. Growth is driven by increasing disease surveillance in endemic regions, expanding access to radical cure therapies, rising investment in malaria elimination programs, and ongoing R&D in anti-relapse drugs and vaccines. Download Full PDF Sample Copy of Marketโ€ฆ
08-20-2025 | Health & Medicine
Exactitude Consultancy
Plasmodium Vivax Malaria Market Outlook 2025-2034, Global Trends and Forecast An โ€ฆ
Plasmodium vivax is one of the most common species of malaria parasites, responsible for a large proportion of malaria cases worldwide. Unlike Plasmodium falciparum, which causes more severe malaria, P. vivax malaria can still lead to significant morbidity and mortality if not properly managed. As global efforts to combat malaria intensify, the Plasmodium vivax malaria market is experiencing notable growth, driven by advancements in treatment options, diagnostics, and vaccine development.โ€ฆ
10-20-2022 | Business, Economy, Finances, B โ€ฆ
Stratagem Market Insights
Highlights On Future Development in Plasmodium Falciparum Diagnostics Market 202 โ€ฆ
The new research study that is being offered here is an excellent compilation of numerous analyses of important elements of the Global Plasmodium Falciparum Diagnostics Market. It clarifies how the Plasmodium Falciparum Diagnostics market is anticipated to expand globally over the course of the projected period 2022-2030. The strengths and weaknesses of the global Plasmodium Falciparum Diagnostics market and the many companies operating therein are thoroughly explained using SWOT analysisโ€ฆ
02-16-2021 | Health & Medicine
KEY ORGANICS LTD
NSTDA-BIOTEC selects Key Organics BIONET Fragment Library to identify new non-py โ€ฆ
The National Center for Genetic Engineering and Biotechnology (BIOTEC) is a research center under the umbrella of the National Science and Technology Development Agency (NSTDA), Ministry of Higher Education, Science, Research and Innovation of Thailand. The center was founded on 20 September 1983 and became a member of NSTDA in 1991. BIOTECโ€™s Health and Medicine program focuses its research and development to advance knowledge on neglected diseases such as malaria. Malariaโ€ฆ
11-05-2018 | Health & Medicine
Allied Market Research
Anti-Malarial Drug Market Size , share and growth with top key players GlaxoSmit โ€ฆ
The global anti-malarial drugs market is gradually developing due to the surge in prevalence rate of malaria globally. Favorable government regulations, development of multi-drug resistance (MDR), and increase in research, development, and innovation in terms of anti-malaria therapeutics is anticipated to supplement market growth. However, possible side effects of anti-malaria drugs such as anxiety, dizziness insomnia, and others impede the growth of this market. Anti-malarial drugs are medications used for theโ€ฆ
07-05-2017 | Health & Medicine
Global Antimalarial Drug Market
Outlook on Global Antimalarial Drug Market Size, Status and Forecast 2022 - Baye โ€ฆ
ResearchMoz added Latest Research Report titled " Global Antimalarial Drug Market Size, Status and Forecast 2022 " to it's Large Report database. This report studies the global Antimalarial Drug market, analyzes and researches the Antimalarial Drug development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like Pfizer GlaxoSmithKline Ranbaxy Laboratories Ipca Laboratories Ltd Zydus Cadila Merck KGaA Novartis AG Alvizia Health Care Bayer Roche Request for Sampleโ€ฆ